Two House committees are now investigating the drug aducanumab, which was approved by the Food and Drug Administration to treat Alzheimer’s disease.
Here & Now‘s Peter O’Dowd talks withDamian Garde, a reporter at STAT.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org.